These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 1342221)

  • 1. Effect of cutaneous cell-mediated immune response to rIFN gamma on Mycobacterium leprae viability in the lesions of lepromatous leprosy.
    Damasco MH; Sarno EN; Lobão AS; Alvarenga FB; Porto JA; Rosankaimer F; Kaplan G
    Braz J Med Biol Res; 1992; 25(5):457-65. PubMed ID: 1342221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular responses to the intradermal injection of recombinant human gamma-interferon in lepromatous leprosy patients.
    Kaplan G; Nusrat A; Sarno EN; Job CK; McElrath J; Porto JA; Nathan CF; Cohn ZA
    Am J Pathol; 1987 Aug; 128(2):345-53. PubMed ID: 3113256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
    Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
    Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of bacilliferous BL/LL cases with combined chemotherapy and immunotherapy.
    Katoch K; Katoch VM; Natrajan M; Bhatia AS; Sreevatsa ; Gupta UD; Sharma VD; Shivannavar CT; Patil MA; Bharadwaj VP
    Int J Lepr Other Mycobact Dis; 1995 Jun; 63(2):202-12. PubMed ID: 7602215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2.
    Kaplan G; Kiessling R; Teklemariam S; Hancock G; Sheftel G; Job CK; Converse P; Ottenhoff TH; Becx-Bleumink M; Dietz M
    J Exp Med; 1989 Mar; 169(3):893-907. PubMed ID: 2494293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The response to chemotherapy of serum Mycobacterium leprae-specific antigen in multibacillary leprosy patients.
    Roche PW; Britton WJ; Neupane KD; Failbus SS; Cho SN; Theuvenet WJ
    Am J Trop Med Hyg; 1991 Jun; 44(6):702-8. PubMed ID: 1858971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy.
    Nathan CF; Kaplan G; Levis WR; Nusrat A; Witmer MD; Sherwin SA; Job CK; Horowitz CR; Steinman RM; Cohn ZA
    N Engl J Med; 1986 Jul; 315(1):6-15. PubMed ID: 3086725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leprosy pseudoimbricata: an unusual presentation of steroid-modified borderline lepromatous leprosy.
    Kumar S; Mehta H; Aggarwal D; Chatterjee D; Narang T; Dogra S
    Int J Dermatol; 2020 Apr; 59(4):e124-e125. PubMed ID: 31957882
    [No Abstract]   [Full Text] [Related]  

  • 10. Lepromatous leprosy treated with recombinant interferon gamma: cutaneous histologic changes.
    Bottasso O; Besuschio S; Merlin V; Morini JC; Bernabo J; Falcoff R; Falcoff E
    Int J Dermatol; 1992 Nov; 31(11):813-7. PubMed ID: 1428437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of multiple interferon gamma injections on the disposal of Mycobacterium leprae.
    Kaplan G; Mathur NK; Job CK; Nath I; Cohn ZA
    Proc Natl Acad Sci U S A; 1989 Oct; 86(20):8073-7. PubMed ID: 2510159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Mycobacterium leprae and its soluble products on the cutaneous responsiveness of leprosy patients to antigen and recombinant interleukin 2.
    Kaplan G; Sampaio EP; Walsh GP; Burkhardt RA; Fajardo TT; Guido LS; de Miranda Machado A; Cellona RV; Abalos RM; Sarno EN
    Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6269-73. PubMed ID: 2668961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of recombinant interferon gamma administration on lesional monocytes/macrophages in lepromatous leprosy patients.
    SivaSai KS; Prasad HK; Misra RS; Ramesh V; Wilfred D; Nath I
    Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):259-69. PubMed ID: 8396615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
    Reitan LJ; Closs O; Belehu A
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a modified WHO regimen in highly bacilliferous BL/LL patients.
    Katoch K; Ramu G; Ramanathan U; Sengupta U; Sreevatsa ; Sharma VD; Shivannavar CT; Katoch VM
    Int J Lepr Other Mycobact Dis; 1989 Jun; 57(2):451-7. PubMed ID: 2664042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The systemic influence of recombinant interleukin 2 on the manifestations of lepromatous leprosy.
    Kaplan G; Britton WJ; Hancock GE; Theuvenet WJ; Smith KA; Job CK; Roche PW; Molloy A; Burkhardt R; Barker J
    J Exp Med; 1991 Apr; 173(4):993-1006. PubMed ID: 2007862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viability of Mycobacterium leprae in lepromatous patients after five years of dapsone monotherapy supplemented with two years of multidrug therapy.
    Sivaprasad N; Snehalatha S; Lobo D; Aschhoff M; Job CK
    Indian J Lepr; 1995; 67(4):427-33. PubMed ID: 8849919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two microbiological relapses in a patient with lepromatous leprosy.
    Chakma JK; Girdhar A; Natrajan M; Kumar A; Girdhar BK
    Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients.
    Sampaio EP; Moreira AL; Sarno EN; Malta AM; Kaplan G
    J Exp Med; 1992 Jun; 175(6):1729-37. PubMed ID: 1588290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.